TRINITY BIOTECH PLC-SPON ADR(NASDAQ:TRIB) stock News

TRIB Latest News, Press Relases and Analysis

All

Press Releases

2 months ago - By: Trinity Biotech plc

Trinity Biotech Regains Compliance with Nasdaq Listing Requirements

2 months ago - By: Trinity Biotech plc

Trinity Biotech Appoints Paul Tivnan as Non-Executive Director

2 months ago - By: Benzinga - Mentions: NBY WINT THAR PPCB ...

12 Health Care Stocks Moving In Wednesday's Intraday Session

2 months ago - By: Trinity Biotech plc

Regulatory Approval Granted for Commencement of Trinity Biotech’s Offshored and Outsourced Manufacturing of its Flagship Rapid HIV Test, Facilitating Strategic and Financial Performance Transformation

2 months ago - By: Benzinga - Mentions: TNXP CASI ADAP PPCB ...

12 Health Care Stocks Moving In Friday's After-Market Session

2 months ago - By: Zacks Investment Research - Mentions: ABT MDT DXCM

Trinity Biotech's Redesigned CGM Sensor Favored by New Clinical Data

2 months ago - By: Stocktwits

Trinity Biotech Stock Marks Best Day Ever On New York Greenlight For Pregnancy Risk Test; Retail Sees More Upside

2 months ago - By: Trinity Biotech plc

Trinity Biotech Receives Regulatory Approval to Begin FDA-Cleared PreClara™ Preeclampsia Testing Service

2 months ago - By: Trinity Biotech plc

Trinity Biotech Achieves Breakthrough Clinical Trial Results for Redesigned CGM Sensor

2 months ago - By: Trinity Biotech plc

Trinity Biotech Announces Launch of FDA-cleared Preeclampsia Testing Service

3 months ago - By: Trinity Biotech plc

Trinity Biotech Unveils CGM+: An AI-Native Platform Targeting the $260 Billion AI Wearable Market

4 months ago - By: Trinity Biotech plc

Trinity Biotech Reaches Profitability Inflection Point, Marking Major Milestone in Strategic Turnaround

4 months ago - By: Trinity Biotech plc

Trinity Biotech Secures Key Regulatory Approval for Offshored and Outsourced Manufacturing of Its Flagship Rapid HIV Test, Accelerating Strategic & Financial Performance Transformation

5 months ago - By: Trinity Biotech plc

Trinity Biotech Publishes Fourth Quarter and Fiscal Year 2024 Financial Results & Provides a Business Update

7 months ago - By: Trinity Biotech plc

Trinity Biotech Receives Non-Compliance Notice Regarding Nasdaq Global Select Requirement for Minimum Market Value of Publicly Held Shares and Nasdaq Minimum Bid Price Requirement

7 months ago - By: Trinity Biotech plc

Trinity Biotech Further Strengthens Focus on Continuous Glucose Monitoring – Appoints Barclays to Advise on Ongoing Strategic Realignment Process

8 months ago - By: Trinity Biotech plc

Trinity Biotech Announces Additional Funding To Support Transformation Plan & Continued Development of the Company’s Continuous Glucose Monitoring Technology

9 months ago - By: Trinity Biotech plc

TRINITY BIOTECH PLC-SPON ADR (TRIB) Stock News

TRIB Latest News, Press Relases and Analysis

Trinity Biotech Regains Compliance with Nasdaq Listing Requirements

Trinity Biotech Appoints Paul Tivnan as Non-Executive Director

12 Health Care Stocks Moving In Wednesday's Intraday Session

Regulatory Approval Granted for Commencement of Trinity Biotech’s Offshored and Outsourced Manufacturing of its Flagship Rapid HIV Test, Facilitating Strategic and Financial Performance Transformation

12 Health Care Stocks Moving In Friday's After-Market Session

Trinity Biotech's Redesigned CGM Sensor Favored by New Clinical Data

Trinity Biotech Stock Marks Best Day Ever On New York Greenlight For Pregnancy Risk Test; Retail Sees More Upside

Trinity Biotech Receives Regulatory Approval to Begin FDA-Cleared PreClara™ Preeclampsia Testing Service

Trinity Biotech Achieves Breakthrough Clinical Trial Results for Redesigned CGM Sensor

Trinity Biotech Announces Launch of FDA-cleared Preeclampsia Testing Service

Trinity Biotech Unveils CGM+: An AI-Native Platform Targeting the $260 Billion AI Wearable Market

Trinity Biotech Reaches Profitability Inflection Point, Marking Major Milestone in Strategic Turnaround

Trinity Biotech Secures Key Regulatory Approval for Offshored and Outsourced Manufacturing of Its Flagship Rapid HIV Test, Accelerating Strategic & Financial Performance Transformation

Trinity Biotech Publishes Fourth Quarter and Fiscal Year 2024 Financial Results & Provides a Business Update

Trinity Biotech Receives Non-Compliance Notice Regarding Nasdaq Global Select Requirement for Minimum Market Value of Publicly Held Shares and Nasdaq Minimum Bid Price Requirement

Trinity Biotech Further Strengthens Focus on Continuous Glucose Monitoring – Appoints Barclays to Advise on Ongoing Strategic Realignment Process

Trinity Biotech Announces Additional Funding To Support Transformation Plan & Continued Development of the Company’s Continuous Glucose Monitoring Technology

Trinity Biotech Reports Landmark First-Day Accuracy Gains in CGM Pre-Pivotal Trial